90 related articles for article (PubMed ID: 809382)
1. A therapeutic trial of fresh plasma infusions over a period of 22 months in two siblings with Hunter's syndrome.
Yatziv S; Statter M; Abeliuk P; Meshulam M; Russel A
Isr J Med Sci; 1975 Aug; 11(8):802-8. PubMed ID: 809382
[TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement therapy by fibroblast transplantation: long-term biochemical study in three cases of Hunter's syndrome.
Dean MF; Stevens RL; Muir H; Benson PF; Button LR; Anderson RL; Boylston A; Mowbray J
J Clin Invest; 1979 Jan; 63(1):138-46. PubMed ID: 105013
[TBL] [Abstract][Full Text] [Related]
3. Effect of leukocyte transfusion in a child with type II mucopolysaccharidosis.
Knudson AG; Di Ferrante N; Curtis JE
Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1738-41. PubMed ID: 4256894
[TBL] [Abstract][Full Text] [Related]
4. [Brain magnetic resonance imaging findings in two cases of Hunter's syndrome].
Okane K; Tomura N; Hirano H; Heian-na J; Watarai J
No To Shinkei; 1998 Mar; 50(3):273-7. PubMed ID: 9566004
[TBL] [Abstract][Full Text] [Related]
5. Inefficacy of fresh frozen plasma therapy of mucopolysaccharidosis II.
Erickson RP; Sandman R; Robertson Wv; Epstein CJ
Pediatrics; 1972 Nov; 50(5):693-701. PubMed ID: 4343502
[No Abstract] [Full Text] [Related]
6. Bone marrow transplantation in Hunter syndrome (mucopolysaccharidosis type II): two-year follow-up of the first Italian patient and review of the literature.
Coppa GV; Gabrielli O; Zampini L; Pierani P; Giorgi PL; Jezequel AM; Orlandi F; Miniero R; Busca A; De Luca T
Pediatr Med Chir; 1995; 17(3):227-35. PubMed ID: 7567644
[TBL] [Abstract][Full Text] [Related]
7. Mucopolysaccharidosis type II (Hunter's syndrome) in Taiwan.
Su PH; Hwu WL; Chiang SC; Chiu PC; Lin SJ; Shu SG; Wang TR
J Formos Med Assoc; 1998 Mar; 97(3):186-90. PubMed ID: 9549269
[TBL] [Abstract][Full Text] [Related]
8. Mucopolysaccharidoses type II: enzymatic activity and quantitative and qualitative studies of urinary glycosaminoglycans in five patients.
Gallegos-Arreola MP; González-Noriega A; Zúñiga-González GM; Flores-Martínez SE; Morán Moguel MC; Figuera LE; Sánchez-Corona J
Arch Med Res; 1997; 28(1):91-4. PubMed ID: 9078594
[TBL] [Abstract][Full Text] [Related]
9. Reduction of GAG storage in MPS II mouse model following implantation of encapsulated recombinant myoblasts.
Friso A; Tomanin R; Alba S; Gasparotto N; Puicher EP; Fusco M; Hortelano G; Muenzer J; Marin O; Zacchello F; Scarpa M
J Gene Med; 2005 Nov; 7(11):1482-91. PubMed ID: 15966019
[TBL] [Abstract][Full Text] [Related]
10. [Hunter's disease: study of a family from the plain of Paestum].
Carlomagno S; Federico A; Pinto L; Balbi R; Vitolo G; Guazzi GC
Acta Neurol (Napoli); 1973; 28(3):323-49. PubMed ID: 4270001
[No Abstract] [Full Text] [Related]
11. HLA alloimmunization with leukocyte concentrates from HLA-matched and HLA-non-matched donors in patients with Hunter's syndrome.
Kakaiya RM; Greenstein R; Pisciotto P; Slocum SK; Rosen D; Cable RG; Morse EE; Gainey A
Ann Clin Lab Sci; 1985; 15(5):435-40. PubMed ID: 3933403
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of a patient transplanted for Hunter's disease type IIB: a case report and literature review.
Bergstrom SK; Quinn JJ; Greenstein R; Ascensao J
Bone Marrow Transplant; 1994 Oct; 14(4):653-8. PubMed ID: 7858546
[TBL] [Abstract][Full Text] [Related]
13. [Unusual findings in 2 patients with Hunter's disease].
Fiehring C; Schramm G; Würbach G; Meerbach W; Koskowski H; Hoffmann W; Hellinger J; Buttenberg H
Dtsch Gesundheitsw; 1970 Jan; 25(2):78-82. PubMed ID: 4245072
[No Abstract] [Full Text] [Related]
14. Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I.
Clarke LA; Wraith JE; Beck M; Kolodny EH; Pastores GM; Muenzer J; Rapoport DM; Berger KI; Sidman M; Kakkis ED; Cox GF
Pediatrics; 2009 Jan; 123(1):229-40. PubMed ID: 19117887
[TBL] [Abstract][Full Text] [Related]
15. [Hunter's syndrome (type II) in a 4-year-old child].
Zoch-Zwierz W; Zadrozna B; Kilczewska D
Wiad Lek; 1976 Apr; 29(7):641-4. PubMed ID: 131419
[No Abstract] [Full Text] [Related]
16. Transplantation of amniotic epithelial membranes in patients with mucopolysaccharidoses.
Akle C; McColl I; Dean M; Adinolfi M; Brown S; Fensom AH; Marsh J; Welsh K
Exp Clin Immunogenet; 1985; 2(1):43-8. PubMed ID: 3939973
[TBL] [Abstract][Full Text] [Related]
17. [Urinary acid mucopolysaccharide-peptide complexes in children. 2. Urinary acid mucopolysaccharide-peptide complexes in Hunter's syndrome].
Ri T
Nihon Shonika Gakkai Zasshi; 1970 Jan; 74(1):137-47. PubMed ID: 4245240
[No Abstract] [Full Text] [Related]
18. Challenges in the Management of Mucopolysaccharidosis Type II (Hunter's Syndrome) in a Developing Country: a Case Report.
Rasheeedah I; Patrick O; Abdullateef A; Mohammed A; Sherifat K; Gbadebo I
Ethiop J Health Sci; 2015 Jul; 25(3):279-82. PubMed ID: 26633932
[TBL] [Abstract][Full Text] [Related]
19. The effect of haematopoietic stem cell transplant on papules with 'pebbly' appearance in Hunter's syndrome.
Ito K; Ochiai T; Suzuki H; Chin M; Shichino H; Mugishima H
Br J Dermatol; 2004 Jul; 151(1):207-11. PubMed ID: 15270893
[TBL] [Abstract][Full Text] [Related]
20. A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome).
Muenzer J; Gucsavas-Calikoglu M; McCandless SE; Schuetz TJ; Kimura A
Mol Genet Metab; 2007 Mar; 90(3):329-37. PubMed ID: 17185020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
